Hepatoprotective activity of Zha xun from different sources of origin
In this study,the pharmacodynamic substance basis of the therapeutic activity of different origin sources of the Tibetan medicinal herb Zha xun was evaluated,and the protective effect of the Zha xun,from Habahe county of Altay region,Xinjiang Uygur Autonomous Region;Gilgit region,Pakistan;Lhozhag county of Lhozhag city,Tibet Autonomous Region;Lhorong county of Chamdo city,Tibet Autonomous Region;and Jiulong county of Ganzi Tibetan Autonomous Prefecture,Sichuan Province,on 0.2％carbon tetrachloride(CC14)-induced acute liver injury in ICR mice was evaluated.The results showed that different sources of Zha xun significantly reduced serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),lactate dehydrogenase(LDH)in the CCl4-induced acute oxidative liver injury model,improved liver histopathological damage.Among them,Zha xun from Habahe County,Altay Region,Xinjiang Uygur Autonomous Region;Gilgit Region,Pakistan;and Lhorong County,Chamdo City,Tibet Autonomous Region significantly reduced the malondialdehyde(MDA)content in liver tissues(P＜0.05),increased the glutathione(GSH)content(P＜0.01),improved the oxidative stress in liver tissues.The preliminary evaluation of the hepatoprotective activity of Zha xun from different origins was carried out using the model of HepG2 cell injury induced by acetaminophen(APAP).The results showed that Zha xun from different origins could significantly inhibit APAP-induced hepatocellular injury and improve the survival rate of hepatocytes.The present study demonstrated that the different origins of Zha xun had definite hepatoprotective activities in vivo and ex vivo,among which,Zha xun from Lhorong County,Chamdo City,Tibet Autonomous Region,had stronger hepatoprotective activities.The animals used in this experiment and the related dispositions were in accordance with the requirements of animal welfare,and the experiment was approved by the Committee of Laboratory Animal Management and Use of the Institute of Pharmaceutical Sciences of the Chinese Academy of Medical Sciences(approval No.00004024)before the experiment was carried out.
NETL
NSTL
万方数据
